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Abstract. 
 
In 
 
Saccharomyces cerevisiae
 
, the unconven-
tional myosin Myo2p is of fundamental importance in 
polarized growth. We explore the role of the neck re-
gion and its associated light chains in regulating Myo2p 
function. Surprisingly, we find that precise deletion of 
the six IQ sites in the neck region results in a myosin, 
 
Myo2-
 
D
 
6IQp, that can support the growth of a yeast 
strain at 90% the rate of a wild-type isogenic strain. We 
exploit this mutant in a characterization of the light 
chains of Myo2p. First, we demonstrate that the local-
ization of calmodulin to sites of polarized growth 
largely depends on the IQ sites in the neck of Myo2p. 
Second, we demonstrate that a previously uncharacter-
ized protein, Mlc1p, is a myosin light chain of Myo2p. 
 
MLC1
 
 (
 
YGL106w
 
) is an essential gene that exhibits 
haploinsufficiency. Reduced levels of 
 
MYO2
 
 overcome 
the haploinsufficiency of 
 
MLC1
 
. The mutant 
 
MYO2-
 
D
 
6IQ
 
 is able to suppress haploinsufficiency but not de-
letion of 
 
MLC1
 
. We used a modified gel overlay assay 
to demonstrate a direct interaction between Mlc1p and 
the neck of Myo2p. Overexpression of 
 
MYO2
 
 is toxic, 
causing a severe decrease in growth rate. When 
 
MYO2
 
 
is overexpressed, Myo2p is fourfold less stable than in a 
wild-type strain. High copies of 
 
MLC1
 
 completely over-
come the growth defects and increase the stability of 
Myo2p. Our results suggest that Mlc1p is responsible for 
stabilizing this myosin by binding to the neck region.
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T
 
he
 
 
 
Saccharomyces cerevisiae
 
 unconventional myo-
sin Myo2p is a member of the class V myosins and
has been implicated in vesicle movement and polar-
ized growth (Johnston et al., 1991; Govindan et al., 1995).
Homologues of Myo2p include mouse 
 
dilute
 
, which plays a
role in melanosome transport (Provance et al., 1996;
Nascimento et al., 1997), and chicken myosin V, which has
a role in neuron filopodial extension (Wang et al., 1996).
Myo2p is essential for growth of 
 
S
 
.
 
 cerevisiae
 
, and it local-
izes to the bud tip during bud formation and to the bud
neck during cytokinesis (Brockerhoff et al., 1994; Lillie
and Brown, 1994). A temperature-sensitive mutation in
 
MYO2
 
 confers defects in polarized growth and in vacuole
inheritance but not in general secretion (Johnston et al.,
1991; Govindan et al., 1995; Hill et al., 1996).
All myosins have at least one light chain that binds to
the myosin heavy chain via a light chain binding motif
called an IQ site (Cheney and Mooseker, 1992; Xie et al.,
1994). IQ sites are often found in tandem repeats between
the head-motor domain and the tail domain (Cheney and
 
Mooseker, 1992; Rayment et al., 1993). IQ sites are 
 
z
 
25–
amino acid residue motifs that bind calmodulin or myosin
light chains. In many cases, the binding of these small
EF-hand proteins activates the Mg
 
2
 
1
 
ATPase activity of
myosins. For example, calmodulin is required for the
Mg
 
2
 
1
 
ATPase activity of chicken myosin V (Espindola et
al., 1992). Furthermore, light chains perform structural
roles by affecting myosin head orientation as well as orien-
tation of light chains to each other. As an example, the
light chains of scallop myosin II are required to stabilize
Ca
 
2
 
1
 
 binding by the myosin head domain and alter the
myosin head orientation (Fromherz and Szent-Gyorgyi,
1995). Myo2p has six tandem IQ sites (Johnston et al.,
1991).
We have previously shown that calmodulin binds to
Myo2p to perform an essential function in polarized
growth (Brockerhoff et al., 1994). Not only is calmodulin
present at sites of polarized growth (Brockerhoff and
Davis, 1992), but calmodulin and Myo2p have direct phys-
ical contact through the IQ sites in the neck of Myo2p
(Brockerhoff et al., 1994). 
 
CMD1
 
 mutants show allele-spe-
cific synthetic lethality with the mutant 
 
myo2-66
 
, thus sug-
gesting that calmodulin and Myo2p share an essential
function.
Interestingly, both class V myosins in 
 
S
 
.
 
 cerevisiae
 
,
Myo2p and Myo4p, confer deleterious effects on cell
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growth when overexpressed (Haarer et al., 1994). Myo4p
localizes to the bud and is essential for the polarized distri-
bution of the asymmetry determinant, Ash1p (Bobola et al.,
1996; Jansen et al., 1996). 
 
MYO4
 
 is not essential for growth
(Haarer et al., 1994). The cause of growth defects when ei-
ther 
 
MYO2
 
 or 
 
MYO4
 
 is overexpressed is unknown.
Here we investigate the role of light chains in the function
of Myo2p. Localization of calmodulin to sites of cell growth
depends on the neck region of Myo2p. The 
 
S
 
.
 
 cerevisiae
 
 ge-
nome sequencing project revealed a small protein with simi-
larities to calmodulin and myosin light chains. We show that
this protein, which we name Mlc1p (myosin light chain), binds
to the myosin neck and regulates the stability of Myo2p.
 
Materials and Methods
 
Plasmids
 
The plasmids used in this study are listed in Table I.
Plasmid pRS28, used to precisely delete 
 
MYO2
 
, was made in several
steps. The 5.6-kb ClaI fragment of pJP10-2B, containing 
 
MYO2
 
, was
 
cloned into the ClaI site of pBluescriptII KS
 
1
 
 (Stratagene, La Jolla, CA)
to make pRS23. In pRS24, the 4.1-kb NdeI-AflII fragment of 
 
MYO2
 
 was
removed. Plasmid pRS24 was digested with EcoRI, the ends were filled in
with the Klenow fragment of DNA polymerase to destroy the EcoRI site,
and the ends were ligated with T4 DNA ligase to make pRS26. The re-
maining coding sequence of 
 
MYO2
 
 in pRS26 was replaced with an EcoRI
site by oligonucleotide-directed mutagenesis (Kunkel et al., 1987)
 
 
 
using
the primer MYO2D (5
 
9
 
-CTCGCGCCATCAGTTGAATTCTATACG-
CTGTAATATCTGCTG-3
 
9
 
), creating plasmid pRS27. In the plasmid
pRS28, a 0.8-kb EcoRI fragment containing 
 
TRP1
 
 (Davis et al., 1986) was
cloned into the EcoRI site of pRS27.
The plasmid shuffle used in this study required a plasmid encoding
 
ADE3
 
 and 
 
MYO2
 
. A 5.6-kb ClaI fragment of 
 
MYO2
 
 was cloned into the
SmaI site of pLI831 (Geiser et al., 1993) to make pRS37. The shuttle vec-
tor pRS50 contains a 2-
 
m
 
m origin from a 2.1-kb EcoRI fragment of YEp24
ligated into the NotI site of pRS37. In both plasmids, the 5
 
9
 
 overhangs
were filled in by treatment with the Klenow fragment of DNA poly-
merase.
Additional plasmids containing 
 
MYO2
 
 were made carrying the 
 
URA3
 
selectable marker. Plasmid pRS25 is a derivative of pRS316 (Sikorski and
Hieter, 1989) in which the HindIII-NotI fragment of the polylinker was
removed, the 5
 
9
 
 overhangs were filled in with Klenow, and the plasmid
was recircularized with T4 DNA ligase. The plasmid pRS29 contains the
5.6-kb ClaI fragment of 
 
MYO2
 
 from plasmid pJP10-2B cloned into the
ClaI site of pRS25. In pRS29, the coding sequence of 
 
MYO2
 
 runs in
 
Table I. Plasmids Used in This Study
 
Plasmid Parent vector Relevant markers and construction* Reference or source
 
pBluescriptII KS (
 
1
 
) amp
 
r
 
 f1 origin Stratagene
pGEX-2T P
 
tac
 
 with gene encoding GST Pharmacia
pQE30 P
 
tac
 
 with 6XHis polylinker Qiagen
pRS306
 
URA3
 
 f1 origin (Sikorski and Hieter, 1989)
pRS315
 
CEN6 ARSH4 LEU2
 
 f1 origin (Sikorski and Hieter, 1989)
pRS316
 
CEN6 ARSH4 URA3
 
 f1 origin (Sikorski and Hieter, 1989)
pGF27 pRS304 2-
 
m
 
m origin (YEp24 fragment) inserted at AatII site G. Zhu
pGF29 pRS306 2-
 
m
 
m origin (YEp24 fragment) inserted at AatII site G. Zhu
pJG28 pSB5 amp
 
r
 
 trc promoter, 
 
CMD1
 
J. Geiser
pJP10-2B YCp50
 
URA3 MYO2 CEN4 ARS1
 
(Johnston et al., 1991)
pLI831 pBluescriptII SK (
 
1
 
)
 
ADE3
 
E. Muller
myo4
 
D
 
::URA3 pBluescriptII KS (
 
1
 
)
 
myo4
 
D
 
::URA3
 
S. Brown
pRS23 pBluescriptII SK (
 
1
 
) 5.6-kb ClaI fragment of 
 
MYO2
 
This study
pRS28 pRS27
 
myo2
 
D
 
::TRP1
 
This study
pRS29 pRS25 5.6-kb ClaI fragment of 
 
MYO2
 
This study
pRS31 pGF29 5.6-kb ClaI fragment of 
 
MYO2
 
This study
pRS43 pRS29 NheI site removed This study
pRS50 pRS37 2-
 
m
 
m origin (YEp24 fragment) inserted at NotI site This study
pRS72 pRS43 NcoI site added at codon 1 of 
 
MYO2
 
This study
pRS172 pRS43 Internal deletion of 
 
MYO2
 
 (S787G This study
 
D
 
aa788–927) also known as 
 
MYO2-D6IQ
 
pRS174 pRS306 5.4-kb ClaI fragment of 
 
MYO2-D6IQ
 
This study
pRS221 pGF29 5.4-kb ClaI fragment of 
 
MYO2-D6IQ
 
This study
pRS276 pBluescriptII KS (
 
1
 
) 3.3-kb BamHI fragment carrying 
 
MLC1
 
This study
pRS286 pRS285
 
mlc1
 
D
 
::TRP1
 
This study
pRS289 pRS316 1.4-kb BamHI-SacI fragment of 
 
MLC1
 
This study
pRS290 pGF27 1.4-kb BamHI-SacI fragment of 
 
MLC1
 
This study
pRS296 pQE30 amp
 
r
 
 promoter 6XHis-
 
MLC1
 
This study
pRS321 pRS315 1.4-kb BamHI-SacI fragment of 
 
MLC1
 
This study
pSB6 pACYC177 kan
 
r
 
 lysis genes of lambda (Brockerhoff et al., 1994)
pSB20 pGEX-3X
 
MYO2
 
 (aa740–1457) fused to GST (Brockerhoff et al., 1994)
pSB21 pGEX-3X
 
MYO2
 
 (aa740–1116) fused to GST (Brockerhoff et al., 1994)
pSB24 pGEX-3X
 
MYO2
 
 (aa790–924) fused to GST (Brockerhoff et al., 1994)
pSB25 pGEX-3X
 
MYO2
 
 (aa740–833) fused to GST (Brockerhoff et al., 1994)
pSB27 pGEX-3X
 
MYO2
 
 (aa247–740) fused to GST (Brockerhoff et al., 1994)
pTD28 pTD17 2-
 
m
 
m origin 
 
LYS2 CMD1
 
(Davis and Thorner, 1989)
pTD29 YEp24 2-
 
m
 
m origin 
 
LYS2
 
(Geiser et al., 1993)
 
*Unless otherwise stated, all markers from the parent plasmid are present in the new construct. 
 
MYO2
 
-
 
D
 
6IQ
 
 encodes an internal deletion in Myo2p with the mutation S787G and
missing amino acids 787–927. 
 
MLC1
 
 is identical to the 
 
Saccharomyces cerevisiae
 
 open reading frame 
 
YGL106w
 
. 
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the  same direction as the f1 origin. For later studies, the NheI site of
pRS29 was removed by digestion with NheI, filling in with Klenow, and
reclosing with T4 DNA ligase to create pRS43. The high-copy number
plasmid pRS31 was created by cloning the 5.6-kb ClaI fragment of 
 
MYO2
 
into the ClaI site of pGF29, a 2-
 
m
 
m plasmid.
Deletion of the region encoding the neck of 
 
MYO2
 
 was made by oligo-
nucleotide-directed mutagenesis (Kunkel et al., 1987). Because of the
large size of 
 
MYO2
 
, a cassette was created containing the middle one-
third of the gene. The 2.6-kb BamHI-EcoRI fragment of 
 
MYO2
 
 was
cloned into the BamHI and EcoRI sites of pBluescriptII KS
 
1
 
 to make
pRS78. The first step towards deleting the six IQ sites was to introduce
NarI restriction endonuclease cleavage sites into the coding sequence of
 
MYO2
 
 at either end of the region encoding the IQ sites. The oligonucle-
otide NAR1 (5
 
9
 
-GCAATAAGATGCATAATGGCGCCATTGTTATGA-
TCCAGAAG-3
 
9
 
) results in the addition of a glycine between amino acid
residues 786 and 787 as well as the mutation S787A. The oligonucleotide
NAR4 (5
 
9
 
-GAAATTGAAACAATTGAAGGGCGCCGACGCTAA-
ATCAGTTAATC-3
 
9
 
) results in the addition of a glycine between amino
acids 927 and 928. After mutating pRS78 using NAR1 and NAR4, the re-
sulting plasmid was digested with NarI and reclosed using T4 DNA ligase.
This mutant cassette was then ligated to BamHI- and EcoRI-cut pRS43 to
create the plasmid pRS172, which encodes a Myo2p with an S787G muta-
tion and lacks only amino acids 788–927. This mutant was named 
 
MYO2-
 
D
 
6IQ
 
. Plasmid pRS221 has the 5.4-kb Asp718-SacI fragment containing
 
MYO2-
 
D
 
6IQ
 
 cloned into pGF29.
The plasmid pRS174 was created to integrate 
 
MYO2-
 
D
 
6IQ into the ge-
nome of S. cerevisiae. pRS174 was made by ligating the 5.4-kb ClaI frag-
ment of pRS172 containing MYO2-D6IQ into the ClaI site of pRS306.
The gene YGL106w encodes a 149–amino acid protein with similarities
to calmodulin. Based on the work described in this paper, we have re-
named YGL106w as MLC1. The 3.3-kb BamHI fragment of lambda PM-
3353 (American Type Culture Collection, Rockville, MD) was cloned into
the BamHI site of pBluescriptII KS1, creating plasmid pRS276. Plasmid
pRS287 is a derivative of pRS276, in which the 2.0-kb NdeI-NotI fragment
was removed, 59 overhangs were filled in with Klenow, and plasmid was
recircularized with T4 DNA ligase. In plasmid pRS287, MLC1 is the only
open reading frame remaining in the pBluescript polylinker.
The plasmid to delete MLC1 precisely was made in a similar way to the
myo2D construct. Plasmid pRS284 was made by digesting pRS276 with
EcoRI, filling in the 59 overhangs with Klenow, and recircularizing the
plasmid with T4 DNA ligase. The coding sequence of MLC1 was replaced
with an EcoRI site by oligonucleotide-directed mutagenesis (Kunkel et al.,
1987) using primer MLC1D (59-CTAAATTTGCAGTTCCGCACTCT-
CAGAATTCTGTTATTCTATGTATGTGCG-39), creating pRS285. A
0.8-kb EcoRI fragment containing TRP1 (Davis et al., 1986) was cloned
into the EcoRI site of pRS285 to make pRS286. In pRS286, the TRP1
gene is in the same orientation as the original MLC1.
Plasmid pRS296, designed to express 6XHis-tagged MLC1 in Escheri-
chia coli, was made in several steps. An NcoI site was placed at the first
codon of MLC1 by oligonucleotide-directed mutagenesis using primer
MLC1-NCOI (59-GGCTCTGGTGGCTGCCATGGTTATTCTAT-
GTATGTGC-39) (Kunkel et al., 1987) to make pRS291. This mutagenesis
also created the mutation S2A. The MLC1 fragment was made by digest-
ing pRS291 with NcoI, filling in using the Klenow fragment of DNA poly-
merase, digesting with SacI, and purifying the 0.8-kb fragment. Plasmid
pRS296 was then made by digesting pQE30 (Qiagen, Inc., Chatsworth,
CA) with BamHI, filling in using the Klenow fragment of DNA poly-
merase, digesting with SacI, and ligating in the 0.8-kb MLC1 fragment.
Media and Strains
Media for growth of S. cerevisiae and E. coli were described previously
(Zhu et al., 1993). The yeast strains used in this study are listed in Table II.
Genetic manipulations and transformations were performed essentially as
described previously (Sherman et al., 1986). RSY2 carrying the deletion of
MYO2 was created by one-step gene replacement (Rothstein, 1991) using
the plasmid pRS28 digested with BglII and ClaI transformed into RSY1.
Because strains containing ade3D-100 are histidine auxotrophs, ADE3 on
a plasmid can be selected by histidine prototrophy (Jones and Fink, 1982).
RSY2 was transformed with pRS50 carrying ADE3 and MYO2. The strain
RSY2-60B has MYO2 deleted from the genome and carries pRS50.
The mutant MYO2-D6IQ was integrated into yeast by two-step gene
replacement (Rothstein, 1991) using plasmid pRS174 digested with
BamHI. Strains RSY21 and RSY22 were shown to contain MYO2-D6IQ
by PCR and by Southern blot analysis. RSY22 was mated to strain
MMY28 carrying an integrated form of GFP–CMD1 (Moser et al., 1997)
to make the diploid strain RSY33. A myo4D::URA3 construct (a gift from
Susan Brown, University of Michigan, Ann Arbor, MI) was transformed
into RSY33 to create strain RSY38, heterozygous for GFP–CMD1,
MYO2-D6IQ, and myo4D.
Strain RSY105 carrying a deletion of MLC1 was difficult to create be-
cause MLC1 displays haploinsufficiency. To create the disruption, we first
transformed JGY46 with plasmid pRS289, carrying the MLC1 gene. The
resulting strain had three functioning copies of MLC1. If one copy of
MLC1 were removed by one-step gene replacement, then the resulting
strain would still have two copies of the gene. The 1.7-kb BamHI-NdeI
fragment of plasmid pRS286 encoding mlc1D::TRP1 was transformed into
JGY46(pRS289). Of the 42 colonies obtained, four were unable to lose
the URA3-marked MLC1 plasmid pRS289 when streaked onto minimal
medium containing 59-fluoro orotic acid (59-FOA).1 These four colonies
were the likely candidates for heterozygous mlc1D strains. To test this hy-
pothesis, the four strains were transformed with the LEU2-marked MLC1
plasmid pRS321 and streaked onto minimal medium containing 59-FOA.
Three of the four strains were able to lose pRS289 when given an alterna-
tive source of MLC1 from pRS321. RSY105 was shown to be heterozy-
gous MLC1/mlc1D::TRP1 by Southern blot analysis. RSY105 must carry a
plasmid source of MLC1 to survive.
To study the null phenotype of mlc1D, strains RSY105(pRS289) and
JGY46 were sporulated on SpoIII medium, and 50 tetrads were dissected
from each strain. After 24 h, spores were examined for germination and
colony growth. Images of spores and colonies were obtained as described
below using a fluorescent microscope (model Axioplan; Carl Zeiss, Inc.,
Thornwood, NY) with 0.3-s, low-light exposures. Germinating spores
were transferred to 20 ml minimal medium containing 3.7% formalde-
hyde. After 60 min at room temperature, 4,69-diamidino-2-phenylindole
(DAPI) was added to a final concentration of 50 mg/ml, and nuclei were
examined as described below.
Immunoblot Analysis
SDS-PAGE and immunoblot analysis were performed as described (Gei-
ser et al., 1991) with the following exceptions. Strains to be analyzed were
grown to 50 Klett units in the appropriate medium. After centrifugation,
cells were washed in lysis buffer (50 mM Tris, pH 8.0, 13 proteinase inhib-
itor cocktail [Drubin et al., 1988]). Cells were lysed by mixing equal vol-
umes of cells, glass beads (Sigma Chemical Co., St. Louis, MO), and lysis
buffer and vortexing five times for 1 min alternating with 1-min incuba-
tions on ice. After centrifugation for 15 min in a microcentrifuge at 48C,
pellets were washed once in lysis buffer and solubilized using cracking
buffer (10 mM sodium phosphate, pH 7.2, 1% b-mercaptoethanol, 1%
SDS, and 6 M urea). For detection of Myo2p, 30 mg of protein was loaded
into each lane of a 6% SDS–polyacrylamide gel. Proteins were transferred
to nitrocellulose membranes using a wet-transfer apparatus (Bio-Rad
Laboratories, Hercules, CA) following the instructions provided by the
manufacturer. The membranes were incubated with a 1:400 dilution of af-
finity-purified anti-Myo2p antibody (Lillie and Brown, 1994). Secondary
antibody was blotting grade goat anti–rabbit IgG horseradish peroxidase
conjugate (Bio-Rad Laboratories) at a 1:5,000 dilution. Signal was de-
tected using Renaissance luminol reagent (DuPont/NEN, Boston, MA)
and Hyperfilm-MP (Amersham Corp., Arlington Heights, IL).
Gel Overlays
Production of 35S-labeled 6XHis-Mlc1p was as follows. The E. coli strain
GM1 (Coulondre and Miller, 1977) containing the plasmids pRS296 and
pSB6 was grown in 30 ml of M9 medium (Miller, 1972) with 1.0 mM
MgCl2 (instead of MgSO4), 0.4% glucose, 1 mg/ml thiamine, 50 mg/ml
ampicillin, 15 mg/ml kanamycin, and 8 mCi carrier-free Na35SO4 (DuPont/
NEN) to 20 Klett units and then induced by adding isopropyl-b-d-thioga-
lactopyranoside to a final concentration of 2 mM. After 5 h at 378C, the
cells were collected by centrifugation and resuspended in 400 ml lysis
buffer (50 mM Tris, pH 7.5, 1 mM MgCl2, and 1 mM phenylmethylsulfonyl
fluoride). The sample was frozen and thawed several times, alternating
1. Abbreviations used in this paper: 59-FOA, 59-fluoro orotic acid; DAPI,
49,6-diamidino-2-phenylindole; GFP, green fluorescent protein; GST, glu-
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between 220 and 208C to lyse the cells, and then centrifuged at 10,000 g
for 30 min in a 48C microcentrifuge. The supernatant fraction was batch
mixed for 10 min with 700 ml preequilibrated Ni-NTA beads (Qiagen,
Inc.). The beads were poured to form a column and washed with 10 ml ly-
sis buffer containing 25 mM imidazole. Purified 6XHis-Mlc1p was eluted
from the column using lysis buffer containing 500 mM imidazole. The imi-
dazole buffer was exchanged with 100 mM ammonium bicarbonate with a
PD-10 G25 column (Pharmacia Biotech, Piscataway, NJ). Protein was
stored at 2808C until needed. Protein concentration was determined using
bicinchoninic acid (Sigma Chemical Co.). The purified 35S-labeled 6XHis-
Mlc1p had a specific activity of 27 dpm/fmol.
Purified 35S-labeled calmodulin was made as previously described (Brock-
erhoff et al., 1992), except that only 8 mCi Na35SO4 was used in the labeling.
The purified 35S-labeled calmodulin had a specific activity of 39 dpm/fmol.
The gel overlay assays for calmodulin and Mlc1p binding were per-
formed as previously described (Brockerhoff et al., 1994) with slight mod-
ifications. In brief, extracts were made from the E. coli strain GM1 (Cou-
londre and Miller, 1977) containing either plasmid pGEX-2T, pSB20,
pSB21, pSB24, pSB25, or pSB27. Approximately 30 mg total protein was
loaded into each lane for SDS-PAGE. Proteins were transferred to Immo-
bilon membranes (Millipore Corp., Bedford, MA) using a wet-transfer
apparatus (Bio-Rad Laboratories) following the instructions provided by
the manufacturer. After transfer, the proteins were renatured by washing
the Immobilon membranes for a total of 40 min (four changes) in buffer A
(20 mM Hepes, pH 7.2, 100 mM NaCl) and blocked for 6 h in buffer A
containing 3% bovine serum albumin and 0.05% Tween-20. The mem-
branes were probed for 16 h at 218C with either 140 mM 35S-labeled
6XHis-Mlc1p or 156 mM 35S-labeled calmodulin in buffer C (buffer A
with 5 mM CaCl2 and 0.05% Tween-20). The membranes were then
washed for 40 min (four changes) in buffer C. Next, the membranes were
air dried, dipped in 7% 2,5-diphenyloxazole in acetone, air dried, and ex-
posed to Hyperfilm-MP (Amersham Corp.) for 5–8 d.
Northern Analysis of MYO2 Transcript
Total mRNA was purified from strains of CRY1 carrying either pRS43,
pRS172, pRS31, or pRS221 using a previously described procedure (Wise,
1991). From 500-ml cultures, z7.0 mg RNA was obtained. Total mRNA
was purified from the samples using the Promega PolyA Tract mRNA
Isolation System I (Madison, WI) with MagneSphere particles. Approxi-
mately 50 mg poly A–containing mRNA was purified from each culture.
Northern blot analysis was performed using standard procedures (Sam-
brook et al., 1989) with the following modifications. 10 mg mRNA was
loaded in each lane of a prerun formaldehyde gel. After removing the
formaldehyde by washing 23 in DEPC dH2O, mRNA was transferred to
a nitrocellulose membrane using capillary transfer (Sambrook et al.,
1989). The membrane was baked at 658C for 1 h. Probes were made using
the 3.4-kb NcoI-EcoRI fragment of MYO2 from pRS72 and a PCR prod-
uct containing a 0.5-kb fragment of TRX2. After incubating the mem-
brane with z1 3 107 cpm of each probe (pooled) for 48 h, the membrane
was washed and analyzed using a Molecular Dynamics PhosphorImager
(model 400S; Sunnyvale, CA) using 176-micron pixel size.
Table II. Yeast Strains
Strain Genotype* Reference
CRY1 MATa ade2-1oc can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 R. Fuller (Stanford University, CA)
JGY46 MATa/MATa ade2-1oc/ade2-1oc can1-100/can1-100 his3- (Geiser et al., 1991)
11,15/his3-11,15 leu2-3,112/leu2-3,112 trp1-1/trp1-1 ura3-1/ura3-1
EMY55-5D MATa ade2-1oc ade3D-100 can1-100 cyh2r his3-11,15 leu2-3,112 lys2D::HIS3 trp1-1 ura3-1 E. Muller (University of
Washington, Seattle, WA)
EMY55-6B MATa ade2-1oc ade3D-100 can1-100 cyh2S his3-11,15 leu2-3,112 lys2D::HIS3 trp1-1 ura3-1 E. Muller (University of
Washington)
MMY28 MATa ade2-1oc ade3D-100 can1-100 (S65T-GFP)–CMD1 his3- (Moser et al., 1997)
11,15 leu2-3,112 lys2D::HIS3 trp1-1 ura3-1
RSY1 EMY55-5D X EMY55-6B This study
RSY2 MATa/MATa ade2-1oc/ade2-1oc ade3D-100/ade3D-100 can1-100/can1-100 cyh2r/cyh2S This study
 his3-11,15/his3-11,15 leu2-3,112/leu2-3,112 lys2D::HIS3/lys2D::HIS3 MYO2/myo2D::TRP1
trp1-1/-trp1-1 ura3-1/ura3-1
RSY2-60B MATa ade2-1oc ade3 D-100 can1-100 his3-11,15 leu2-3,112 This study
lys2D::HIS3 myo2D::TRP1 trp1-1 ura3-1 carrying plasmid pRS50
RSY21 MATa ade2-1oc can1-100 his3-11,15 leu2-3,112 MYO2-D6IQ trp1-1 ura3-1 This study
RSY22 MATa ade2-1oc can1-100 his3-11,15 leu2-3,112 MYO2-D6IQ trp1-1 ura3-1 This study
RSY38 MATa/MATa ade2-1oc/ade2-1oc ADE3/ade3D-100 can1-100/can1-100 CMD1/GFP–CMD1 This study
 his3-11,15/his3-11,15 leu2-3,112/leu2-3,112 MYO2/MYO2-D6IQ MYO4/myo4D::URA3
trp1-1/trp1-1 ura3-1/ura3-1
RSY38-9D MATa ade2-1oc ade3D-100 can1-100 GFP–CMD1 his3-11,15 This study
leu2-3112 lys2D::HIS3 MYO2-D6IQ trp1-1 ura3-1
RSY38-16A MATa ade2-1oc ade3D-100 can1-100 GFP–CMD1 his3-11,15 This study
leu2-3,112 lys2D::HIS3 myo4D::URA3 trp1-1 ura3-1
RSY38-16C MATa ade2-1oc ade3D-100 can1-100 his3-11,15 leu2-3,112 This study
lys2D::HIS3 MYO2-D6IQ myo4D::URA3 trp1-1 ura3-1
RSY38-17C MATa ade2-1oc ade3D-100 can1-100 GFP–CMD1 his3-11,15 This study
leu2-3,112 lys2D::HIS3 trp1-1 ura3-1
RSY105 MATa/MATa ade2-1 oc/ade2-1 oc can1-100/can1-100 his3- This study
11,15/his3-11,15 leu2-3,112/leu2-3,112 MLC1/mcl1D::TRP1
trp1-1/trp1-1 ura3-1/ura3-1 carrying plasmid pRS289
RSY105-6A MATa ade2-1oc can1-100 his3-11,15 leu2-3,112 mcl1D::TRP1 This study
trp1-1 ura3-1 carrying plasmid pRS289
RSY107 RSY21 X RSY105-6A carrying plasmid pRS289 This study
RSY112 MATa/MATa ade2-1oc/ade2-1oc ade3D-100/ade3D-100 can1-100/can1-100 his3-11,15/his3-11,15 This study
 leu2-3,112/leu2-3,112 lys2D::HIS3/lys2D::HIS3 MLC1/mcl1D::TRP1
MYO2/myo2D::TRP1 trp1-1/trp1-1 ura3-1/ura3-1 carrying plasmid pRS289
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Indirect Immunofluorescence and Green Fluorescent 
Protein Fusions
The immunolocalization of Myo2p in strains CRY1 and RSY21 was per-
formed as previously described (Brockerhoff et al., 1994; Lillie and
Brown, 1994).
The localization of GFP–Cmd1p in strains RSY38-9D, RSY38-16A,
RSY38-16C, and RSY38-17C was performed using a fluorescent micro-
scope (model Axioplan; Carl Zeiss, Inc.) (Moser et al., 1997). 200 cells from
each strain were scored for the presence of polarized calmodulin. Calmod-
ulin was judged to be polarized if the fluorescent signal was stronger in the
bud than in the mother portion of each cell. Images were captured using
an Imagepoint-cooled CCD video camera (Photometrics, Tucson, AZ) fit-
ted to the microscope in conjunction with IP Lab software (Signal Analyt-
ics, Vienna, VA). Images for GFP–calmodulin are 5-s exposures. Previous
studies have shown that expression of GFP alone in yeast resulted in a
uniform distribution of fluorescence throughout the cell, excluding the
vacuole (Niedenthal et al., 1996).
Results
Myo2p Functions without a Neck Domain
The neck of Myo2p contains six IQ sites in a tandem array
spanning amino acids 790–921 (Johnston et al., 1991).
Myo2p is essential for growth, but the six IQ sites are not.
The mutant MYO2-D6IQ, lacking the sequence encoding
amino acids 787–927, supports nearly normal growth as
the only source of Myo2p, causing only a 10% reduction in
growth rate (Fig. 1). An immunoblot confirmed that neck-
less Myo2-D6IQp is stably produced and that no wild-type
Myo2p is present in the strain (Fig. 1 C). The mutant cells
have a normal budding index but on average are 10%
larger in size. The distribution of bud sizes was similar to
that seen in wild-type cultures. The mutant cultures con-
tained about 5% large unbudded cells not found in the
wild-type cultures. A strain carrying MYO2-D6IQ does
not grow at 38.58C, whereas an isogenic wild-type strain
grows poorly. A strain carrying MYO2-D6IQ grows well
on medium with or without 1 M sorbitol (data not shown).
The neckless mutant protein localizes indistinguishably
from that of wild-type Myo2p (Fig. 2). In both cases, un-
budded cells have either no localization or a small patch of
Myo2p. In small- and medium-budded cells, the Myo2p is
present in a concentrated region at the bud tip. In large-
budded cells, the Myo2p is either at the bud tip or at the
bud neck (Fig. 2). These results are consistent with previ-
ous analysis of Myo2p localization (Brockerhoff et al.,
1994; Lillie and Brown, 1994).
Neckless MYO2-D6IQ Affects Calmodulin Localization
Our previous results strongly suggest calmodulin is a light
chain of Myo2p. Calmodulin localizes to the sites of cell
Figure 1. The mutant MYO2-D6IQ allows growth. Strains carry-
ing wild-type MYO2 (CRY1) or MYO2-D6IQ (RSY21) were
plated on YPD medium and incubated for 3 d at 30 and 378C (A).
Log-phase cultures were diluted to 10,000 cells/ml in YPD me-
dium, and growth was monitored over 4 h. Cell number was de-
termined on a Coulter counter (Coulter Corporation, Hialeah,
FL). (B) j, wild-type MYO2 strain, CRY1; d, MYO2-D6IQ
strain, RSY21. An immunoblot of extracts made from log-phase
cultures of strains CRY1 and RSY21 (C). The antibody was anti-
Myo2p (Lillie and Brown, 1994).
Figure 2. Comparison of the localization of Myo2p and Myo2-
D6IQp. Cells were stained with affinity-purified anti-Myo2p anti-
body as described in Materials and Methods. Cells were simulta-
neously stained with DAPI to stain DNA. Bar, 5 mm.The Journal of Cell Biology, Volume 142, 1998 716
growth, and calmodulin mutants display defects in polar-
ized growth (Brockerhoff and Davis, 1992; Davis, 1992;
Ohya and Botstein, 1994). Mutations in CMD1 exacerbate
defects caused by myo2-66 in an allele-specific manner.
The viability of the MYO2-D6IQ strain allows us to test if
the localization of calmodulin at sites of cell growth de-
pends on the six IQ sites of Myo2p. Localization of a fu-
sion of GFP to calmodulin was examined in wild-type and
neckless mutant strains. GFP–calmodulin functionally re-
places calmodulin and localizes properly (Moser et al.,
1997). In a strain carrying wild-type MYO2, GFP–calmod-
ulin is found at sites of cell growth in 84% of the cells (Fig.
3 and Table III). This number is equivalent to values ob-
tained by immunolocalization (Brockerhoff and Davis,
1992). The cells without polarized calmodulin are either
large-budded cells in the process of moving calmodulin
from the bud tip to the bud neck or unbudded cells that
have not yet started bud formation. In a strain carrying
MYO2-D6IQ, only 15% of the cells have polarized cal-
modulin with greatly reduced and more diffuse signal even
in these cells. Myo4p localizes diffusely in the yeast bud
(Jansen et al., 1996). We tested whether the remaining
GFP–calmodulin in the bud of the MYO2-D6IQ strain was
dependent on Myo4p, which is not essential for growth.
Strains deleted for MYO4 and containing wild-type
MYO2 show the same localization of GFP–calmodulin as
a wild-type strain containing both MYO4 and MYO2.
However, in a strain carrying MYO2-D6IQ and myo4D,
GFP–calmodulin is polarized in only 4% of the cells (Fig. 3
and Table III). Thus, calmodulin localization to sites of
polarized growth is largely dependent on the six IQ sites of
Myo2p, although Myo4p contributes to a small extent.
MLC1, a New Light Chain
The newly completed genome sequence for S. cerevisiae
identified a potential myosin light chain. YGL106w en-
codes a 149–amino acid polypeptide with significant ho-
mology to calmodulin and myosin light chains. Based on
the results described below, we have renamed this gene
MLC1. An alignment with vertebrate calmodulin and the
most similar light chain reveals homology throughout the
Figure 3. Localization of GFP–calmodulin in myo4D strains. Cultures of RSY38-17c (WT), RSY38-16A (myo4D MYO2), RSY38-9D
(MYO4 MYO2-D6IQ), and RSY38-16C (myo4D MYO2-D6IQ) were grown to log phase. Samples were collected, mixed with equal vol-
umes of 1% agarose dissolved in SDC, and mounted on microscope slides for image collection as described in the Materials and Meth-
ods. Bar, 5 mm.
Table III. Calmodulin Localization in Myosin Mutants
Genotype Polarized calmodulin (%)
Wild type 84
myo2-D6IQ 15
myo4D 80
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sequences (Fig. 4). Mlc1p shares 35% identity with verte-
brate calmodulin, second to only yeast calmodulin among
yeast proteins (Davis and Thorner, 1986). Mlc1p is 35%
identical to a chicken light chain (MLE1) (Matsuda et al.,
1981). Mlc1p is 31% identical to Acanthamoeba myosin 1C
light chain, another unconventional myosin light chain
(Wang et al., 1997).
MLC1 Is Essential and Displays Haploinsufficiency
Initial attempts to make a diploid hemizygous for MLC1
were unsuccessful. Southern blot analysis revealed that
one-step gene replacement (Rothstein, 1991) resulted in
strains containing at least two wild-type copies of MLC1
for every one copy of the deletion construct. One possible
explanation for this effect is that one copy of MLC1 per
diploid genome is insufficient for viability. This phenome-
non is called haploinsufficiency (Wilkie, 1994). We tested
if MLC1 is haploinsufficient by repeating the gene disrup-
tion in a strain carrying two copies of MLC1 in the genome
plus one copy of MLC1 on a plasmid. In this case, we were
able to delete one copy of MLC1 from the genome as de-
scribed in the Materials and Methods. The hemizygous dip-
loid requires a plasmid carrying MLC1 for viability (Fig. 5).
Haploid spores that contain the mlc1D gene disruption re-
quire MLC1 on a plasmid (data not shown). Therefore,
MLC1 is haploinsufficient and essential.
To begin characterizing the phenotype of mlc1D cells,
we examined spores from a hemizygous diploid strain. The
diploid requires a plasmid copy of MLC1 to survive. Any
spores receiving the plasmid would grow into colonies
even if they carried the genomic copy of mlc1D. The mlc1D
spores that did not inherit the plasmid were identified as
the 20% of the spores that germinated but did not form
colonies. The mlc1D cells grew elongated buds (Fig. 6).
Cytokinesis was not complete because removal of the cell
wall by treatment with zymolyase did not result in separa-
tion of the buds from the mother cells. DAPI staining re-
vealed that the elongated cells have multiple nuclei (Fig. 6
C). Less than 1% of the spores from the control strain
formed elongated cells.
Mlc1p Interacts with the Neck of Myo2p
Two lines of evidence suggest Mlc1p is a light chain of
Myo2p. First, the haploinsufficiency exhibited by MLC1 is
suppressed by reduced copies of MYO2 (Fig. 5). A diploid
strain hemizygous for both MYO2 and MLC1 is viable.
Figure 4. Alignment of the
predicted amino acid se-
quence of MLC1 with three
other small EF-hand proteins.
Vertebrate calmodulin (Homo
sapiens) amino acids 7–149, a
chicken light chain (Gallus
gallus, MLE1) amino acids
45–190, and Acanthamoeba
myosin IC light chain (A. cas-
tellanii, MICLC) amino acids
7–149 are compared with the
complete amino acid sequence
of Mlc1p. Amino acid residues
sharing identity between
Mlc1p and at least one of the
other sequences are shaded.
Amino acids within potential
Ca21-binding loops are la-
beled  with a solid line.
Figure 5. MLC1 displays
haploinsufficiency. Strains
JGY46, RSY105, RSY107,
and RSY112, each carrying
the MLC1 plasmid pRS289,
were streaked onto both min-
imal medium lacking uracil
and minimal medium contain-
ing 59-FOA (which will kill
any cells that require the plas-
mid pRS289). The plates were
incubated at 308C for 3 d.The Journal of Cell Biology, Volume 142, 1998 718
Suppression of the haploinsufficiency by hemizygous
MYO2 demonstrates that Mlc1p must ordinarily be
present at the minimum level necessary for cell growth.
MYO2-D6IQ can also suppress the haploinsufficiency of
MLC1 (Fig. 5). However, MYO2-D6IQ cannot bypass the
requirement for Mlc1p in a haploid strain (data not
shown), so there must be at least one other essential func-
tion of Mlc1p in yeast.
Second, Mlc1p binds directly to the IQ sites of Myo2p as
assayed by a gel overlay protocol. The constructs used in
this experiment are presented in Fig. 7. 6XHis-Mlc1p
binds specifically to the fusion proteins that contain IQ
sites (Fig. 8 B). As a control, we show calmodulin also
binds specifically to fusion proteins that contain IQ sites
(Fig. 8 C). Both calmodulin and 6XHis-Mlc1p bind equally
well in the presence of Ca21 or EGTA (data not shown).
These data demonstrate that Mlc1p has a direct interac-
tion with the IQ sites of Myo2p.
The Toxicity of Overexpressed MYO2 Is Suppressed by 
MLC1 but Not CMD1
We looked for a functional interaction between Mlc1p and
Myo2p. A yeast strain carrying a high-copy number plas-
mid of MYO2 grows 40% slower than strains with normal
levels of MYO2 (data not shown). Microscopy has re-
vealed that 5% of cells in the MYO2 overexpression strain
have abnormal bud necks or multiple buds (data not
shown). A similar defect in high-copy number MYO4
strains may be caused by the neck region of Myo4p, and
overexpression of calmodulin does not suppress this effect
(Haarer et al., 1994). One possibility is that high copies of
myosin light chains will overcome defects associated with
MYO2 overexpression.
A strain overexpressing MYO2 shows a noticeable re-
duction in growth rate (Fig. 9 A). The same strain over-
expressing MYO2-D6IQ grows normally. Northern blot
analysis reveals that both MYO2 and MYO2-D6IQ are
transcribed to similar steady-state levels in these two
strains and at least fivefold over normal levels (Fig. 9 B).
Surprisingly, the immunoblot for a strain overexpressing
MYO2 does not show higher levels of Myo2p (Fig. 9, C
and D). In fact, Myo2p seems to actually decrease in the
strain overexpressing MYO2. Overexpressing MYO2-
D6IQ results in high levels of Myo2-D6IQp (Fig. 9, C and D).
Figure 6. mlc1D spores have defects in cell separation. Strains
JGY46 and RSY105(pRS289) were sporulated and tetrads were
dissected. After 24 h, spores were characterized into classes: (1)
germinated and formed colonies, (2) germinated and did not
form colonies, or (3) did not germinate. Examples of each class
are shown (A). 200 spores from each strain were classified (B).
Germinated spores from RSY105(pRS289) were stained with
DAPI. Elongated spores with DAPI staining are shown (C).
Bars, 10 mm.
Figure 7. Glutathione-S-transferase (GST)–Myo2p fusion pro-
teins.Stevens and Davis M1c1p Is a Myosin Light Chain for Myo2p 719
We hypothesized that high levels of calmodulin or
Mlc1p would counteract the toxicity of overexpressed
MYO2. Overexpressing CMD1 is unable to overcome the
decreased growth rate (Fig. 9 A) or the low levels of
Myo2p (Fig. 9 D) caused by overexpressed MYO2. In con-
trast, a high-copy number plasmid carrying MLC1 is able
to fully suppress the overexpression MYO2 defects and re-
sults in a strain that has high levels of Myo2p (Fig. 9, A and
C). These results indicate that the neck region of MYO2 is
indeed responsible for an overexpression growth defect
and that this toxicity is overcome by high levels of Mlc1p.
Mlc1p Stabilizes Myo2p
Because high copies of MLC1 are able to overcome de-
fects caused by overexpression of MYO2, we tested the
hypothesis that Mlc1p stabilizes Myo2p. Yeast cultures
were analyzed for the stability of Myo2p by following
Myo2p breakdown by immunoblot analysis (Fig. 10). In a
wild-type strain, Myo2p has a half-life of greater than 8 h.
In a strain carrying MYO2-D6IQ, the Myo2-D6IQp has a
half-life of greater than 8 h. The neckless Myo2-D6IQp is
at least as stable as wild-type Myo2p. When overex-
pressed, the half-life of Myo2p is only 2–3 h. These data
explain why the Myo2p levels in the overexpression strain
are not increased. In a strain overexpressing MYO2 and
carrying high copies of MLC1, the half-life of Myo2p is 4 h.
High copies of MLC1 are able to stabilize Myo2p, thus
suggesting Mlc1p is a light chain responsible for stabilizing
the neck region of Myo2p.
Discussion
Electron micrographs of the chicken myosin V molecule
show two heads connected to a 30-nm stalk. At the proxi-
mal end of each head is a 20-nm neck that likely corre-
sponds to the six IQ sites (Cheney et al., 1993). This region
is predicted to be an a-helix as is the neck of class II myo-
sins. In class II myosins, the neck region is stabilized by the
binding of the myosin light chains (Rayment et al., 1993;
Houdusse and Cohen, 1996). Calmodulin is the previously
identified light chain for both the chicken and the yeast
myosin V (Cheney et al., 1993; Brockerhoff et al., 1994).
However, calmodulin does not stabilize the yeast myosin.
Here, we present evidence that MLC1 (YGL106w) en-
codes a new light chain for the yeast class V myosin
Myo2p. Our results argue that Mlc1p binds to the neck re-
gion and stabilizes Myo2p.
When overexpressed, Myo2p has a decreased half-life
and is toxic to yeast cells. Overproduction of calmodulin
does not affect the stability of Myo2p, but overproduction
of Mlc1p stabilizes Myo2p and ameliorates the toxicity.
The requirement for Mlc1p to stabilize Myo2p is bypassed
by deleting the six IQ sites in Myo2p. Thus, the presence
of the IQ sites destabilizes Myo2p unless sufficient Mlc1p
is present.
Removal of the IQ sites in Myo2p causes a slightly
slower growth rate and slightly larger cells. A mutant Dic-
tyostelium myosin II heavy chain DBLCBS, which lacks
the two IQ sites, maintains 20% wild-type motor activity
when measured in the sliding filament assay (Uyeda et al.,
1996). The DBLCBS myosin allows cell division in vivo but
demonstrates slightly slowed furrow formation during cy-
tokinesis (Zang et al., 1997). Thus, both Myo2-D6IQp and
the  DBLCBS myosin confer relatively minor defects.
These results indicate that the full efficiency of the myosin
is not essential for myosin function in vivo.
MLC1 is essential and haploinsufficient. Haploinsuffi-
ciency is rarely observed in yeast genes. There are several
reasons reduction in the number of gene copies may have
Figure 8. Gel-overlay assays show in vitro binding of Mlc1p and calmodulin to the IQ sites of Myo2p. Myo2p fusion proteins were ex-
pressed and subjected to SDS-PAGE as described in Materials and Methods. Polyacrylamide gel stained with Coomassie blue. The full-
length fusion protein in each extract is marked by an arrow (A). Autoradiographs of membranes incubated with 35S-labeled 6XHis-
Mlc1p (B) and 35S-labeled calmodulin (C). The gel overlay assays were performed as described in Materials and Methods. Lanes 1–6
contain extracts of IPTG-induced E. coli strain GM1 containing plasmids pGEX-2T, pSB20, pSB27, pSB21, pSB24, and pSB25, respec-
tively. See Fig. 7 and Table I for a description of the fusion proteins.The Journal of Cell Biology, Volume 142, 1998 720
deleterious effects. In some cases, reduced gene copy
number affects regulatory genes working at a threshold
level (Wilkie, 1994). An example of this form of regulation
is dosage-dependent sex determination in Drosophila. Al-
ternately, some proteins may be produced at the minimum
level to give proper function. The ACT1 gene displays
temperature-sensitive growth defects and increased osmo-
sensitivity when present at low levels (Shortle et al., 1984).
Finally, the stoichiometry of various protein components
may be important. Several lines of evidence suggest that a
fixed ratio between Mlc1p and Myo2p is required to con-
fer normal growth. First, a diploid yeast strain carrying
one copy of MLC1 can only grow if there is no more than
one copy of wild-type MYO2. Second, the growth defects
associated with a yeast strain overexpressing MYO2 are
eliminated by adding extra copies of MLC1. Finally, re-
moval of the IQ binding sites from Myo2p rescues the hap-
loinsufficiency exhibited by MLC1.
Myo2-D6IQp does not overcome a requirement of
Mlc1p for cell viability. This observation does not address
the essential nature of the interaction between Mlc1p and
Myo2p. It merely demonstrates that Mlc1p must have at
least one essential function that does not involve binding
to the neck of Myo2p. None of the other four myosins in
yeast are essential for growth (Brown, 1997), suggesting
that Mlc1p has an essential function unrelated to myosins.
Inviable mlc1D cells show a striking defect in cytokinesis,
resulting in enlarged, multinucleate cells. This phenotype
is identical to defects detected in cells deleted for IQG1,
which encodes a newly discovered IQGAP family member
Figure 9. High copies of
MLC1, but not high copies of
CMD1, overcome the toxic
effects of overexpressed
MYO2. Plasmids used in
these experiments are listed
in Table I. EMY55-5D was
transformed with plasmids
encoding high copies of
MYO2,  MYO2-D6IQ,  CMD1,
or  MLC1. Plates were incu-
bated for 3 d at 308C (A).
CRY1 was transformed with
pRS43, pRS172, pRS31, or
pRS221, and mRNA was col-
lected from log-phase cul-
tures. 10 mg of polyA-con-
taining RNA samples were
analyzed as described in Ma-
terials and Methods. Blots
were simultaneously hybrid-
ized with MYO2 and TRX2
32P-labeled probes (B). CRY1
was transformed with the in-
dicated constructs to study
the effects of high copies of
MLC1 (pRS290) on strains
with one extra copy of
MYO2 (pRS43) or one ex-
tra  copy of MYO2-D6IQ
(pRS172), or overexpressing
MYO2 (pRS31) or MYO2-
D6IQ (pRS221) (C). CRY1
was transformed with the in-
dicated constructs to study
the effects of high copies of
CMD1 (pTD28) on strains
overexpressing  MYO2 (pRS31)
or  MYO2-D6IQ (pRS221)
(D). Log-phase extracts were
made as described in Materi-
als and Methods. Samples
were assayed by immunoblot
analysis using anti-Myo2p
antibody (Lillie and Brown,
1994) to detect steady-state
levels of Myo2p.Stevens and Davis M1c1p Is a Myosin Light Chain for Myo2p 721
in yeast (Epp and Chant, 1997; Lippincott and Li, 1998).
Iqg1p contains five IQ sites that could act as binding sites
for Mlc1p. We propose that one essential function of
Mlc1p is to act as a light chain for IQGAP.
Calmodulin is an additional light chain for Myo2p. We
have previously shown that calmodulin and Myo2p coim-
munoprecipitate from yeast cell extracts and interact in
vitro. A mutation that is in the actin-binding site of Myo2p
and interferes with Myo2p function dramatically worsens
the phenotype conferred by mutations in calmodulin
(Brockerhoff et al., 1994). Here we show that the localiza-
tion of calmodulin to sites of cell growth is predominately
dependent on the IQ sites of Myo2p with only a small con-
tribution by the other yeast class V myosin Myo4p. In a
MYO2-D6IQ strain lacking MYO4, calmodulin localizes to
the spindle pole body and to fast moving patches on the
cell surface. The protein target that binds calmodulin in
these fast moving patches has yet to be identified. The
IQGAP protein in yeast localizes to the actin ring at the
bud neck during cytokinesis (Epp and Chant, 1997; Lip-
pincott and Li, 1998). Because calmodulin localization to
the bud neck during cytokinesis depends on Myo2p, either
calmodulin does not bind to yeast IQGAP or calmodulin
binds IQGAP at levels below detection.
Only one other noncalmodulin unconventional myosin
light chain has been characterized. Biochemical studies
identified MICLC as a light chain for Acanthamoeba myo-
sin IC (Wang et al., 1997). Mlc1p and MICLC share 31%
sequence identity, and both proteins share significant
identity with other calmodulin/EF-hand superfamily mem-
bers. The chicken class V myosin has at least three light
chains, calmodulin and two additional uncharacterized
small proteins that copurify with the myosin (Cheney et al.,
1993). These two small proteins have yet to be identified.
In conclusion, we presented several lines of evidence
that Myo2p has at least two light chains, calmodulin and a
newly characterized protein, Mlc1p. Mlc1p regulates the
stability of Myo2p by binding to the neck region. Our
characterization of Mlc1p may aid in the identification of
the additional light chains of the chicken class V myosins.
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